Pzena Investment Management LLC reduced its stake in shares of Morgan Stanley (NYSE:MS – Free Report) by 0.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 748,984 shares of the financial services provider’s stock after selling 1,204 shares during the period. Pzena Investment Management LLC’s holdings in Morgan Stanley were worth $94,162,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of the stock. Geode Capital Management LLC raised its position in shares of Morgan Stanley by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 25,240,729 shares of the financial services provider’s stock worth $2,621,140,000 after purchasing an additional 269,633 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of Morgan Stanley by 1.9% during the 4th quarter. Fisher Asset Management LLC now owns 22,833,937 shares of the financial services provider’s stock worth $2,870,683,000 after purchasing an additional 428,956 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Morgan Stanley by 0.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 11,019,694 shares of the financial services provider’s stock worth $1,385,396,000 after purchasing an additional 47,699 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Morgan Stanley by 4.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,454,177 shares of the financial services provider’s stock worth $881,263,000 after purchasing an additional 385,780 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in shares of Morgan Stanley by 75.2% during the 3rd quarter. Franklin Resources Inc. now owns 7,850,848 shares of the financial services provider’s stock worth $881,493,000 after purchasing an additional 3,369,520 shares during the last quarter. 84.19% of the stock is currently owned by institutional investors and hedge funds.
Morgan Stanley Stock Down 6.4 %
Shares of NYSE MS opened at $111.61 on Tuesday. Morgan Stanley has a 52-week low of $85.01 and a 52-week high of $142.03. The firm has a fifty day moving average of $132.28 and a 200-day moving average of $122.20. The stock has a market capitalization of $180.00 billion, a PE ratio of 14.06, a P/E/G ratio of 1.18 and a beta of 1.35. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14.
Morgan Stanley Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Friday, January 31st were given a dividend of $0.925 per share. The ex-dividend date of this dividend was Friday, January 31st. This represents a $3.70 dividend on an annualized basis and a yield of 3.32%. Morgan Stanley’s dividend payout ratio (DPR) is 46.60%.
Analysts Set New Price Targets
Several research analysts recently issued reports on MS shares. Hsbc Global Res downgraded Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th. Wells Fargo & Company upgraded Morgan Stanley from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $107.00 to $142.00 in a report on Friday, November 15th. Bank of America boosted their price target on Morgan Stanley from $146.00 to $153.00 and gave the company a “buy” rating in a report on Friday, January 17th. Keefe, Bruyette & Woods boosted their price target on Morgan Stanley from $138.00 to $145.00 and gave the company a “market perform” rating in a report on Friday, January 17th. Finally, Evercore ISI boosted their price target on Morgan Stanley from $140.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 17th. Eleven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Morgan Stanley has a consensus rating of “Hold” and a consensus target price of $131.27.
Read Our Latest Stock Report on MS
Insider Buying and Selling
In related news, insider Eric F. Grossman sold 13,097 shares of the company’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $136.20, for a total transaction of $1,783,811.40. Following the completion of the sale, the insider now directly owns 197,444 shares of the company’s stock, valued at approximately $26,891,872.80. This represents a 6.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Raja Akram sold 17,500 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $136.01, for a total transaction of $2,380,175.00. Following the sale, the chief financial officer now directly owns 81,440 shares of the company’s stock, valued at approximately $11,076,654.40. This trade represents a 17.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is owned by corporate insiders.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
See Also
- Five stocks we like better than Morgan Stanley
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- How to Protect Your Portfolio When Inflation Is Rising
- What Investors Need to Know About Upcoming IPOs
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- P/E Ratio Calculation: How to Assess Stocks
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.